Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases

Journal of Medicinal Chemistry
P N Praveen RaoEdward E Knaus

Abstract

A group of 1,3-diarylprop-2-yn-1-ones (13, 17, 23, 26 and 27) possessing a C-3 p-SO2Me COX-2 pharmacophore were designed, synthesized and evaluated as potential dual inhibitors of cyclooxygenase-1/2 (COX-1/2) and 5/15-lipoxygenases (5/15-LOX) that exhibit vivo antiinflammatory and analgesic activities. Among this class of compounds, 3-(4-methanesulfonylphenyl)-1-(4-fluorophenyl)prop-2-yn-1-one (13h) was identified as a potent and selective inhibitor of COX-2 (COX-2 IC50 = 0.1 microM; SI = 300), being 5-fold more potent than rofecoxib (COX-2 IC50 = 0.5 microM; SI > 200). In a rat carrageenan-induced paw edema assay 13h exhibited moderate antiinflammatory activity (26% inhibition of inflammation) at 3 h after administration of a 30 mg/kg oral dose. A related dual COX-1/2 and 5/15-LOX inhibitor 3-(4-methanesulfonylphenyl)-1-(4-cyanophenyl)prop-2-yn-1-one (13g, COX-1 IC50 = 31.5 microM; COX-2 IC50 = 1.0 microM; SI = 31.5; 5-LOX IC50 = 1.0 microM; 15-LOX IC50 = 3.2 microM) exhibited more potent antiinflammatory activity (ED50 = 90 mg/kg), being superior to the reference drug aspirin (ED50 = 129 mg/kg). Within this group of compounds 3-(4-methanesulfonylphenyl)-1-(4-isopropylphenyl)prop-2-yn-1-one (13e) emerged as having an optimal c...Continue Reading

References

Nov 1, 1996·Nature Structural Biology·C LuongM F Browner
Jan 23, 1999·The New England Journal of Medicine·J M DrazenP M O'Byrne
Jun 20, 2001·Bioorganic & Medicinal Chemistry Letters·K L WeissR W Curley
Sep 14, 2002·The Journal of Organic Chemistry·Yasunari MaedaSakae Uemura
Dec 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·C A WINTERG W NUSS
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Yurngdong JahngEung-Seok Lee
Jul 21, 2004·Trends in Cardiovascular Medicine·Lei Zhao, Colin D Funk
Jul 29, 2004·Mini Reviews in Medicinal Chemistry·Fabien JulémontXavier de Leval
Nov 30, 2004·Journal of Medicinal Chemistry·Nicole PommeryJean-Pierre Hénichart
Apr 2, 2005·Journal of Medicinal Chemistry·Jean-Michel DognéDomenico Pratico
Jun 30, 2005·Arthritis and Rheumatism·Daniel H Solomon

❮ Previous
Next ❯

Citations

Oct 18, 2011·Cancer Metastasis Reviews·Claus Schneider, Ambra Pozzi
May 6, 2011·Journal of Medicinal Chemistry·Zheng ChenLuhua Lai
Jan 18, 2016·European Journal of Medicinal Chemistry·Marco MiglioreRita Scarpelli
Apr 7, 2009·European Journal of Pharmacology·Guang-Lin XuTing Xue
Sep 12, 2009·Basic & Clinical Pharmacology & Toxicology·Guang-Lin XuTing Xue
Jul 16, 2008·International Immunopharmacology·Balajikarthick SubramanianRobert Nicolosi
Dec 23, 2016·Medicinal Research Reviews·Catarina Pereira-LeiteSalette Reis
Apr 8, 2015·Organic & Biomolecular Chemistry·Wanfang Li, Xiao-Feng Wu
Jul 8, 2016·Organic & Biomolecular Chemistry·Ole TietzFrank R Wuest
Mar 16, 2018·Chemistry & Biodiversity·Jie-Li LüLai-Bin Zhang
Feb 26, 2010·Expert Opinion on Therapeutic Patents·Carlo Pergola, Oliver Werz
Feb 29, 2008·The Journal of Pharmacology and Experimental Therapeutics·Tracy A BrooksThomas P Davis
Jan 5, 2018·SAR and QSAR in Environmental Research·O KouatlyA Geronikaki
Mar 4, 2008·Journal of Medicinal Chemistry·Athina A GeronikakiAnil K Saxena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here